Psychedelic Mental HealthKetamine and Esketamine in Neurology and Psychiatry: An Overview (Honnekeri, 2026) https://pubmed.ncbi.nlm.nih.gov/42117097/ “#ketamine and #esketamine represent a developing area in the treatment of TRD and highlight the broader emergence of interventional approaches in psychiatry“ #depression #mentalhealth #psychedelics
Ketamine and Esketamine in Neurology and Psychiatry: An Overview - PubMed
Treatment-resistant depression (TRD) remains a significant clinical concern, particularly in patients who do not achieve adequate response with conventional antidepressant therapies. Ketamine and esketamine, which act on glutamatergic pathways, have been introduced into clinical practice as alternat …